Home » Alnylam to Participate in Major Obesity Research Grant Awarded to Scientists at University of Texas (UT) Southwestern Medical Center
Alnylam to Participate in Major Obesity Research Grant Awarded to Scientists at University of Texas (UT) Southwestern Medical Center
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced its participation in a $22 million Roadmap Grant from the National Institutes of Health (NIH) awarded to leading scientists at UT Southwestern for research on obesity.
Alnylam
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May